Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,762
Closed -$388K 979
2025
Q4
$388K Buy
7,762
+35
+0.5% +$1.68K 0.02% 327
2025
Q3
$382K Hold
7,727
0.02% 331
2025
Q2
$403K Buy
7,727
+2,327
+43% +$107K 0.02% 326
2025
Q1
$255K Hold
5,400
0.01% 388
2024
Q4
$279K Hold
5,400
0.01% 382
2024
Q3
$242K Hold
5,400
0.01% 399
2024
Q2
$219K Hold
5,400
0.01% 395
2024
Q1
$218K Sell
5,400
-828
-13% -$31.1K 0.01% 403
2023
Q4
$237K Hold
6,228
0.01% 379
2023
Q3
$176K Sell
6,228
-750
-11% -$23.5K 0.01% 401
2023
Q2
$214K Hold
6,978
0.01% 386
2023
Q1
$218K Buy
6,978
+1,300
+23% +$49.5K 0.01% 374
2022
Q4
$215K Hold
5,678
0.01% 355
2022
Q3
$215K Hold
5,678
0.01% 344
2022
Q2
$207K Sell
5,678
-1,242
-18% -$51.4K 0.01% 359
2022
Q1
$339K Hold
6,920
0.02% 332
2021
Q4
$331K Hold
6,920
0.02% 336
2021
Q3
$304K Hold
6,920
0.02% 341
2021
Q2
$304K Sell
6,920
-1,300
-16% -$61.1K 0.02% 342
2021
Q1
$376K Sell
8,220
-1,000
-11% -$41.9K 0.02% 314
2020
Q4
$298K Buy
+9,220
New +$267K 0.02% 319
2020
Q3
Sell
-14,945
Closed -$307K 318
2020
Q2
$307K Hold
14,945
0.03% 258
2020
Q1
$262K Hold
14,945
0.03% 254
2019
Q4
$586K Sell
14,945
-2,428
-14% -$89.2K 0.05% 219
2019
Q3
$621K Buy
17,373
+7,750
+81% +$278K 0.05% 213
2019
Q2
$337K Buy
+9,623
New +$334K 0.03% 252

Other funds holding SNV

Montag & Associates's SNV Position: Q1 2026 in Review

Montag & Associates sold out of Synovus (SNV) in Q1 2026, closing a stake of 7,762 shares — an estimated $388K sold.

Montag & Associates first reported a position in SNV in Q2 2019 and held it in 26 quarters. The position peaked at $621K in Q3 2019. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Montag & Associates reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Montag & Associates sold 7,762 Synovus shares in Q1 2026, an estimated $388K.
  • Montag & Associates first reported a position in Synovus in Q2 2019 and held it in 26 quarters.
  • Montag & Associates's Synovus position peaked at $621K in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.